Irene J. Vergilis-Kalner, MD, FAAD, FACMS
Board-Certified Dermatologist
Fellowship-Trained Mohs Surgeon

Medical School:

Boston University School of Medicine

Dermatology Research Fellowship:

New York University School of Medicine

Internal Medicine Internship: 

Long Island Jewish Medical Center of the Albert Einstein College of Medicine.

Dermatology Residency:

University of Chicago Medical Center

Mohs Micrographic Surgery and Procedural Dermatology Fellowship:

DermSurgery Associates, affiliated with Weill Cornell Medical College and Methodist Hospital

American Board of Dermatology
American College of MOHS Surgery

Sarkar-Agrawal P, Vergilis I, Sharpless NE, DePinho R, Ruenger TM.  Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.  J Natl Cancer Inst. 2004 Dec 1;96(23):1790-3.

Runger TM, Vergilis I, Sarkar P, DePinho RA, Sharpless NE.  How disruption of cell cycle regulating genes might predispose to sun-induced skin cancer.  Cell Cycle. 2005 May;4(5):643-5.

Vergilis IJ, Szarek M, Ferrone S, Reynolds SR.  Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma.  J Invest Dermatol. 2005 Sep;125(3):526-31.

Reynolds SR, Vergilis IJ, Szarek M, Ferrone S, Bystryn JC.  Cytoplasmic Melanoma Associated Antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?  Int J Cancer. 2006 Jul 1;119(1):157-61.

Vergilis-Kalner IJ, Sharma V, Sethi, A.  Lichen Planus Arising in Radiation Therapy Treatment Sites.  Cutis.  2008 Nov; 82(5): 353-5.

Querfeld C, Vergilis-Kalner I, Petronic-Rosic V, Shea CS, Smith S.  Waxing and waning dermal nodules.  Oncology News International.  2008  17(6): 38 and 46.

Vergilis-Kalner IJ, Mann D, Wasserman J, Petronic-Rosic V, Tsoukas MM.  Pityriasis Rubra Pilaris sensitive to NB-UVB light therapy.  J Drugs Dermatol. 2009 Mar; 8(3): 270-3.

Vergilis-Kalner IJ, Kriseman Y, Goldberg LH.  Keratoacanthomas: overview and comparison between Houston and Minneapolis experiences.  J Drugs Dermatol. 2010 Feb; 9(2): 117-21.

Brach JP, Vergilis-Kalner I, Goldberg LH.  Update to where was that biopsy taken?  Dermatol Surg. 2010 Jun; 36(6): 963-4.

Vergilis-Kalner I, Goldberg LH.  Vertical Undermining for the Closure of Partial Thickness Surgical Defects.  J Drugs Dermatol.  2010 June; 9(6): 674-76

Vergilis-Kalner IJ, Friedman PM, Goldberg LH.  Long-Pulse 595-nm Pulsed Dye Laser for the Treatment of a Glomus Tumor.  Dermatol Surg. 2010 Jul 8. [Epub ahead of print]

Mann DJ, Vergilis-Kalner IJ, Wasserman JR, Petronic-Rosic V.  Folliculocentric lichen sclerosus et atrophicus.  Skinmed. 2010 Jul-Aug; 8(4): 242-4.

Vergilis-Kalner IJ, Goldberg LH.  Bilobed flap for reconstruction of defects of the helical rim and posterior ear.  Dermatol Online J. 2010 Oct; 16(10): 9.

Goldberg LH, Kaplan B, Vergilis-Kalner I, Landau J.  Liquid Nitrogen: Temperature Control in the Treatment of Actinic Keratosis.  Dermatol Surg. 2010 Dec; 36(12): 1956-61.

Vergilis I, Goldberg LH, Landau J, Maltz A.  Transmission of Pseudomonas aeruginosa from Nail to Wound Infection.  Dermatol Surg.  2011 Jan; 37(1): 105-106.

Vergilis-Kalner IJ, Goldberg LH, Firoz B, Landau JM, Kimyai-Asadi A, Marquez D, Friedman PM.  Horizontal excision of in situ epidermal tumors using a flexible blade.  Dermatol Surg.   2011 Feb; 37(2): 234-6.

Landau JM, Vergilis-Kalner I, Goldberg LH, Geronemus RG, Friedman PM.  Treatment of Nevus of Ota in Fitzpatrick skin type VI with the 1064-nm QS Nd:YAG laser.  Lasers Surg Med. 2011 Feb; 43(2): 65-7.

Polder KD, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Friedman PM, Bruce S.  Laser eradication of pigmented lesions: a review.  Dermatol Surg. 2011 May; 37(5): 572-95.

Goldberg LH, Landau JM, Moody MN, Vergilis-Kalner IJ.  Treatment of Bowen’s Disease on the Penis with Low Concentration of a Standard Mixture of Solasodine Glycosides and Liquid Nitrogen.  Dermatol Surg. 2011 Jun; 37(6): 858-61.

Moody MN, Landau JM, Goldberg LH, Marquez D, Vergilis-Kalner IJ.  595 nm long pulsed dye laser with a hydrocolloid dressing for the treatment of hypergranulation tissue on the scalp in postsurgical defects.  Dermatol Online J. 2011 Jul 15;17(7):2.

Moody MN, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Marquez D, Friedman PM.  1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser and 1,550-nm Fractionated Erbium-Doped Fiber Laser for the Treatment of Nevus of Ota in Fitzpatrick Skin Type IV.  Dermatol Surg. Dermatol Surg. 2011 Aug;37(8):1163-7.

Vergilis-Kalner IJ.  Same-patient prospective comparison of botox versus dysport for the treatment of primary axillary hyperhidrosis and review of literature.  J Drugs Dermatol. 2011 Sep 1;10(9): 1013-5.

Landau JM, Moody MN, Goldberg LH, Vergilis-Kalner IJ.  An Unusual Presentation of Idiopathic Basal Cell Carcinoma in an 8-Year-Old Child.  Pediatr Dermatol. 2011 Oct 4.

Goldberg LH, Landau JM, Moody MN, Marquez D, Jih M, Kimyai-Asadi A, Friedman PM, Busch A, Vergilis-Kalner IJ.   Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.  J Drugs Dermatol. 2012 May;11(5):593-7.

Vergilis-Kalner IJ.  Is white coat hypertension a concern in Mohs micrographic surgery?  J Drugs Dermatol. 2012 Sep;11(9):e18-22.

Vergilis-Kalner IJ, Cohen JL. The use of photodynamic therapy as chemoprevention for the treatment of actinic keratoses and reduction in the number of non-melanoma skin cancers.  J Drugs Dermatol. 2013 Oct;12(10):1085-6

Vergilis-Kalner IJ, Cohen J.  Response to the possibility of the application of topical photodynamic therapy leading to development of more histologically aggressive subtypes of Basal cell carcinomas.  J Drugs Dermatol. 2014 Mar;13(3):241-2.

Vergilis-Kalner IJ.  Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.  J.Dermatol Online J. 2014 Jun 15;20(6): 13030/qt1mc5v5mx.

Kalner S, Vergilis IJ.  Periorbital erythema as a presenting sign of COVID-19.  JAAD Case Reports. 2020 Oct;6(10):996-998.

Kalner S, Vergilis IJ.  The hair loss burden of Covid-19.  Accepted for publication J Drugs Dermatol February, 2022.

Wolsky R, Wasserman J, Vergilis I, Tsoukas M.  Cutaneous manifstations of a systemic infection by a rare atypical organism: Mycobacterium Szulgai.  (Submitted for publication to JAAD).